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Abstract
Human natural killer (NK) lymphocytes should not damage autologous cells due to the engagement of inhibitory receptor
superfamily (IRS) members by HLA-I. Nevertheless, NK cells kill self cells expressing low levels or lacking HLA-I, as it may
occur during viral infections (missing-self hypothesis). Herein, we show that human NK cells can be activated upon binding
with self antigen presenting cells or stromal cells despite the expression of HLA-I. Indeed, NK cells can kill and produce pro-
inﬂammatory and regulating cytokines as IFN-g, TNF-a and IL10 during interaction with autologous dendritic cells or bone
marrow stromal cells or skin ﬁbroblasts. The killing of antigen presenting and stromal cells is dependent on LFA1/ICAM1
interaction. Further, the natural cytotoxicity receptors (NCR) NKp30 and NKp46 are responsible for the delivery of lethal hit
to DC, whereas NKG2D activating receptor, the ligand of the MHC-related molecule MIC-A and the UL16 binding protein,
is involved in stromal cell killing. These ﬁndings indicate that different activating receptors are involved in cell to self cell
interaction. Finally, NK cells can revert the veto effect of stromal cells on mixed lymphocyte reaction further supporting the
idea that NK cells may alter the interaction between T lymphocytes and microenvironment leading to autoreactivity.
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Introduction
The adaptive immune response represents an import-
ant component of host defence against infections and
thus critical for health (Janaway 1992). However,
adaptive immune responses sometimes are elicited
against self-antigens and this promotes severe diseases
(Janaway 1992, Goodnow 1996, lanzavecchia and
Sallusto 2001, von Herrath and Harrison 2003).
Normally, self-tolerance mechanisms prevent auto-
immune disease: It is thought that these mechanisms
take place both within the thymus and in the
periphery. The main target of these mechanisms is
the immunocompetent cell represented by B and T
lymphocytes, which can recognize the antigen via their
antigen receptor. Several clues are used by the
immune system to distinguish self ligands from non-
self ligands. Indeed, an ineffective immune response
could occur when the ligand is encountered by an
immature lymphocyte leading to death or to inacti-
vation. Alternatively, the presence of high and stable
concentration of ligand (as it happens for self-
antigens) can result in tolerance; further, the absence
of co-stimulatory signals may impair lymphocyte
response to self-ligands. In these tolerizing processes,
as well as during adaptive immune response against
non-self antigens the innate arm of the immune
system play a key role (Janaway 1992). Dendritic cells
(DC) that are considered a bridge between innate and
acquired immunity, are specialized antigen presenting
cells (APC) of myeloid origin responsible for the
adequate antigen presentation and for T lymphocyte
activation (Lanzavecchia and Sallusto 2001); the lack
of co-stimulatory molecules on DC determine an
abortive immune response leading to tolerance. It is
conceivable that perturbation of these processes may
lead to undesired events as the triggering of
autoimmune diseases.
Among the various effectors cells of the innate arm
of immune system natural killer (NK) lymphocytes
may inﬂuence the outcome of adaptive immune
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as well as stromal cells. In this review, we will analyse
this interaction and discuss the consequences with
respect to initiate autoimmune reaction.
Results and discussion
Human NK cells recognize self-HLA class I through
the engagement of inhibitory receptors superfamily (IRS)
Human NK cells play a role in eliminating virus-
infectedcellsaswellasincontrollingtumorcellgrowth
(Trinchieri 1989). This lymphocyte population orig-
inate from bone marrow where it resides and
recirculate from the peripheral blood. NK cells are
the most cytolytic effector lymphocytes, which can kill
target cells without prior sensibilization. By contrast
with cytolytic T lymphocytes, NK cells apparently
recognize targets lacking HLA class I and peptide.
Paradoxically, NK cell-mediated activities are down
regulated by interacting with HLA class I (Figure 1A).
Indeed, NK lymphocytes are characterized by the
surface expression of receptors for self-HLA class I
molecules including some members of the inhibitory
receptor superfamily (IRS), whose engagement leads
to the inhibition of cytolysis and cytokine production.
Thus, according to the missing self hypothesis, NK
cells can kill targets that do not express (or express low
levels)ofHLAclassI,suchastumorandvirus-infected
cells (Figure 1C) (Farag et al. 1947, Ljunggren and
Karre 1990, Moretta et al. 1996, Lanier 1998, Long
1999).
According to this hypothesis, NK cells do not exert
any activity against self as usually host tissues express
HLA class I. However, this is in contrast with the
ﬁnding that, although some tissues do not bear HLA
class I, they are not damaged by NK cells. In addition,
the discovery of isoforms of IRS that, upon
recognition of HLA class I, deliver an activating signal
in NK cells that leads to the triggering of cytolytic
activity and cytokine release indicate that NK cells can
be actually activated by self-HLA class I (Figure 1)
(Farag et al. 1947, Moretta et al. 1996, Lanier 1998,
Long 1999). To conciliate these conﬂicting ﬁndings it
has been stated that the negative signal delivered via
inhibiting IRS always overcomes the activating ones
when these two opposite signals take place in close
proximity. Alternatively, it has been shown that the
afﬁnity of inhibiting forms for a given HLA class I is
higher than that of activating IRS (Farag et al. 1947,
Moretta et al. 1996, Lanier 1998, Long 1999).
However, as both activating and inhibiting IRS are
clonally distributed and each IRS can recognize one or
a limited number of HLA class I alleles it is possible
Figure 1. Missing self-hypothesis to explain the lack of NK cell aggression to autologous cells. NK cells bear at the cell surface members of
the IRS of the inhibiting type (iIRS) recognizing self-HLA-I: iIRS engagement delivers an inhibiting signal that overcomes the activating one
initiated through activating receptors (aR)-activating receptor ligand (aRL) interaction (A); this results in absence of lysis. This inhibiting
signal is blocked by the addition of anti-HLAI mAb to the cytolytic assay (B) that impair HLA-I-iIRS interaction; this results in the
reconstitution of lytic effect. Panel (C). The lysis of self-cell expressing low levels (or lacking) HLA-I can occur because the inhibiting signal
does not overcome the activating one. Panel (D). This scenario is complicated by the presence, in any healthy donor, of NK cells with
activating isoforms of IRS (aIRS): Their engagement with self-HLA-I leads to activation of NK cell-mediated cytolysis and cytokine release.
Thus,the outcomeofNKcell-self cellinteractionwould be theresultofthebalancebetweenactivating andinhibitingsignalsdependingon the
expression and physical localization of aIRS, iIRS, aR and aRL. In each panel, the balance between activation (green) and inactivation of lysis
(red) is shown. In red are depicted the inhibitory receptors, in green the activating ones. Yellow receptors are the IRS with activating function.
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inhibiting one for different HLA class I alleles; this
implies that, to overcome the activating signals,
inhibiting IRS are engaged together activating IRS
by the corresponding HLA class I allele and this is far
from to be demonstrated. In addition, it should be
noted that the large majority of experimental data
supporting the idea that HLA class I protect self cells
from NK cell-mediated injury, derives from the
ﬁnding that monoclonal antibodies (mAb) to HLA
class I and/or to inhibiting IRS strongly enhance the
lytic activity of NK cells when added to a cytolytic
assay using phytohemoagglutinin (PHA) activated
lymphocytes as targets (Figure 1B) (Farag et al. 1947,
Ljunggren and Karre 1990, Moretta et al. 1996,
Lanier 1998, Long 1999). Few data are reported using
target cells from tissues other than peripheral blood.
Further, APC (Carbone et al. 1999, Wilson et al.
1999, Parajuli et al. 1999, Spaggiari et al. 2001,
Ferlazzo et al. 2002, Pende et al. 2005) cells have been
reported to be optimal targets for NK cell-mediated
killing, indicating on one hand that the protecting role
of HLA class I is relevant in particular for lymphocytes
and on the other hand that additional receptors may
play a role in distinguishing between self and non-self
(Figure 1D).
Interaction between NK cells and APC: Role of natural
cytotoxicity receptors (NCR)
Autologous IL2 activated NK cell populations are
able to lyse freshly isolated APC including monocytes
or monocyte-derived DC cultured for 7 days with
appropriate combination of cytokines as GM-CSF
and IL4 and/or TNF-a which are known to induce
monocyte maturation toward DC. As shown in
Figure 2, the NK cell-mediated lysis of self-APC is
stronger against DC cultured with GM-CSF, IL4 and
TNF-a compared to APC obtained with GM-CSF
alone or in combination with IL4 or ex vivo isolated
monocytes (Spaggiari et al. 2001). On the other hand,
resting NK cells are not able to kill self-APC,
although they efﬁciently lysed K562 tumor cells line
(Figure 2A). That NK cells can damage APC was
further conﬁrmed by the analysis of a series of NK
cell clones. Indeed, two groups of NK cell clones
could be identiﬁed on the basis of the degree of APC
lysis: the ﬁrst group strongly killed self-APC while the
Figure 2. NK cell-mediated lysis of APC is initiated via the engagement of NKp30 and NKp46. Panel (A). IL2-activated NK cells lyse APC
such as monocytes (Mo) or as monocytes cultured with differentiating cytokines, whereas ex vivo isolated NK cells do not. Panel (B). This
effect is strictly related to the expression of NKp30and NKp46 (NCR)activating receptors.The tworepresentativeNK cell clones M21.6 and
M12.3 bearing a bright expression of NKp30 and NKp46 killed self-APC, whereas the S3.25 and A12.12 NCR
dull NK cell clones did not.
Panel (C). The addition of anti-NKp30 and/or NKp46 mAb strongly inhibited the lysis of APC exerted by NK cells. Results are expressed as
%
51Cr speciﬁc release in a 4h cytolytic assay at effector (E, NK cell) target (T, self APC) ratio of 10:1 (A) 20:1, 10:1, 5:1 (B) and 10:1 (C),
respectively. Results obtained with anti-CD56 mAb are shown for comparison.
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which efﬁciently lysed self APC expressed high levels
of the recently identiﬁed NCR (Moretta et al. 2001)
NKp30, NKp44 and NKp46 activating receptors at
the cell surface; by contrast, a low expression (10-fold
lower) of these receptors was found on NK cell clones
which do not lyse APC (Figure 2B). This ﬁnding
suggests that the expression of NCR directly
correlates with APC killing. To determine whether
these receptors are actually involved in NK cell
mediated killing of APC we performed some
experiments in the presence of anti-NCR monoclonal
antibodies. Indeed, it has been shown that the
covering of these receptors with speciﬁc anti-NCR
mAb leads to the inhibition of cytolysis of several
tumor targets as a consequence of the lack of
interaction of NCR (Moretta et al. 2001), expressed
on NK cells, with their putative ligand(s) on target
cells. As shown in Figure 2C, the addition of anti-
NKp30 or anti-NKp46 mAb to the cytolytic assay
reduced by approximately 50% the lysis of autologous
APC. Further, the addition of anti-NKp30 and
anti-NKp46 mAb in combination led to a complete
inhibition of APC lysis. This indicates that these two
NCRs are the surface molecular structures involved in
the delivering of the lethal hit to APC (Spaggiari et al.
2001). To determine the biochemical mechanism by
which NK cell clones lyse self-APC via the engage-
ment of NKp30 and NKp46, cytolytic assay were
performed in the presence of the phosphatidyl-
inositol-3 kinase inhibitors wortmannin (irreversible)
or LY294002 (reversible). Indeed, APC lysis
was strongly inhibited (up to 80%) by blocking
PI-3K with micromolar concentrations of LY294002
or nanomolar concentrations of wortmannin
(Figure 3A). The engagement of NKp30 or NKp46
with speciﬁc mAbs leads to the activation of
Akt/PKB, which is a speciﬁc PI-3K substrate
(Figure 3B) and the same PI-3K inhibitors impaired
the killing in a re-directed killing assay of the FcgR
þ
target cell P815 initiated via NKp30 or NKp46 (not
shown). Altogether, these ﬁndings strongly suggest
that the molecular mechanism underlying the lysis
of autologous APC by NK cells is linked to the
PI-3K/Akt signal transduction pathway (Spaggiari
et al. 2001).
Figure 3. Involvement of PI-3K and CAMKII in NK-APC interaction. Lack of the protective effect by HLAI. Panel (A). Lysis of APC was
inhibited in a dose dependent manner by the addition of the PI-3K inhibitors wortmannin or LY294002. Panel (B). Activity of Akt/PKB, a
downstream substrate of PI-3K, is enhanced by the engagement of NKp30 or NKp46. Panel (C). Lysis of APC is inhibited by the CAMKII
inhibitor KN62 and by the addition of anti-LFA1 or anti-ICAM1 mAb. Panel (D). The covering of HLA-I does not enhance the lysis of APC
whereas self-PHA blasts, as expected, are lysed only in the presence of anti-HLA-I mAb. Results in panel (A), (C) and (D) are expressed as %
51Cr speciﬁc release at the E/Tratio of 10:1. Resultsin panel (B) are expressedas Akt activity (cpm) using the speciﬁc substrate and g-
32PA TP
after immunoprecipitation with anti-Akt speciﬁc mAb. Akt activity was analyzed at different time points (1, 3, 5min) and data presented
referred to min 3 of stimulation with medium (nil) or mAb to the indicated molecules followed by goat anti-mouse cross-linking.
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lymphocytes
Lysis of target cells by NK cells requires a number of
steps: Target cell binding, calcium entry and release
of lytic enzymes (Trinchieri 1989, Leibson 1997,
Moretta et al. 2001, Ferlazzo et al. 2002, Pende et al.
2005). Among the surface structures involved in
effector-target cell interaction LFA1 play a key role in
cell–cell adhesion as well as in delivering an
activating signal. Thus, we further investigated
which role may have LFA1 in NK cell-mediated
APC lysis. It has been demonstrated that the
engagement of LFA1 on NK cells can induce calcium
inﬂuxes through L-type calcium channels and that
calcium is needed to deliver the lethal hit (Zocchi
et al. 1998). Thus, the interaction between NK and
APC evoked a strong calcium inﬂux accompanied by
the activation of the calcium-calmodulin kinase II
(CAMKII) which can be blocked by the CAMKII
inhibitor KN62 and masking LFA1, with the F(ab0)2
of the speciﬁc mAb (or anti-ICAM1 mAb), con-
ceivably inhibiting cell to cell contact (Figure 3C).
Further, the oligomerization of LFA1 elicited by the
addition of goat anti-mouse antiserum on NK cells
preincubated with anti-LFA1 mAb induced a strong
activation of CAMKII (not shown) this close relates
to the inhibition of APC lysis exerted by CAMKII
inhibitors and anti-LFA1 mAb. Altogether, these
ﬁndings suggest that during NK cell to APC binding
the activation of CAMKII initiated via LFA1 is
responsible for the consequent killing of self APC
(Poggi et al. 2002).
Role of HLA-class I in NK cell-mediated lysis of APC
To determine the role of HLA class I in the lysis of
self APC, we analyzed a panel of NK cell clones for
their cytolytic activity in the presence of anti-HLA
class I speciﬁc mAb. As shown in Figure 3D the
NCR
bright 28.12 NK cell clone lysed APC but not
PHA blasts. The covering of the HLA class I
molecules slightly increased the lysis of APC but
strongly enhanced that of PHA blasts indicating that
members of the IRS are actually playing an
inhibitory effect when PHA blasts are used as target
cells. Further, a similar increase of PHA blasts lysis
in the presence of anti-HLA class I mAb was
observed using the NCR
dull 66.25 NK cell clone
which do not lyse APC (Spaggiari et al. 2001).
Although not shown, similar results were obtained
using anti-IRS mAbs. These ﬁndings together with
the observation that APC lysis was enhanced by APC
treatment with TNF-a, which actually upregulates
HLA class I expression, strongly suggest that the
inhibiting signal initiated through the IRS-HLA
class I engagement do not overcome the NCR-
mediated activating signal (Spaggiari et al. 2001).
However, we cannot exclude that the TNF-a
treatment of APC upregulates, beside HLA class I,
also the still undeﬁned ligands of NKp30 and
NKp46 thus favouring the activation lytic machinery.
Phenotypic and functional characterization of bone
marrow stromal cells (BMSC)
Apparently, only IL2 activated NK cells lyse self-APC
(Carbone et al. 1999, Wilson et al. 1999, Parajuli et al.
1999,Spaggiarietal.2001,Ferlazzoetal.2002,Pende
et al. 2005) suggesting that physiologically this killing
occurs at the interface between host and the outer
environment, for instance at the mucosal site during
viral infections when NK cells are activated. However,
NK cells reside in the bone marrow and conceivably
can interact with bone marrow stromal cells (BMSC)
(Trinchieri 1989). BMSC are thought to have a role in
the regulation of hemopoietic stem cell proliferation
and differentiation as well as in the growth of some
hemopoietic malignancies (Rodriguez Mdel et al.
2004, Podesta et al. 2005, Vodyanik et al. 2005).
Morerecently,ithasbeenreportedthatwithinthebone
marrowstromaarepresentthemesenchymalstemcells
(MSC)(Pittengeretal.1999,Sekiyaetal.2002).MSC
are characterized by the ability of differentiating into
mesodermic tissues or even into epithelial cells and
neurons (Woodbury et al. 2000). MSC can exert a
tolerogenic effect on T lymphocyte activation and
proliferation through the release of immunoregulating
cytokinesastransforminggrowthfactorb(TGFb)and
hepatocyte growth factor (HGF) or indoleamine 2,3
dioxygenase; moreover, T lymphocyte-MSC contact
can lead to T-cell tolerance (Di Nicola et al. 2002, Tse
et al. 2003, Le Blanc 2003, Potian et al. 2003, Djouad
et al. 2003, Meisel et al. 2004, Beyth et al. 2005,
AggarwalandPittenger2005).Thissupportstheuseof
MSC to favour bone marrow engraftment and avoid
graft-versus-host disease (GVHD) (Le Blanc et al.
2004).AsithasbeenreportedthatMSCcancooperate
with immunosuppressive drugs to ameliorate GVHD,
it is important to determine whether the innate arm of
the immune system may interact with BMSC and/or
MSC and the consequence of this interaction. Bone
marrow cell suspensions were isolated and cultured
accordingtopreviousreports(DiNicolaetal.2002,Le
Blanc 2003, Potian et al. 2003, Djouad et al. 2003,
Meisel et al. 2004, Beyth et al. 2005, Aggarwal
and Pittenger 2005) and BMSC were obtained
after 15–21 days of culture. At this time surface
phenotype of adherent cells was the following:
99%SH3/CD73
þSH4
þSH2/CD105
þ100%CD44
þ
b1-integrin(CD29)
þICAM1(CD54)
þ100%HLA-I
þ
and CD40
þ, 98%CD45
2CD31
2CD34
2 CD33
2
CD3
2 CD2
2 CD16
2 CD14
2 ICAM2
2 ICAM3
2
CD80
2CD86
2 CD83
2 HLA-DR
2.M i c r o s c o p i c
analysis revealed two types of cells (Figure 4A):
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phology which can be considered “bona ﬁde” MSC as
they are able to differentiate into adipocytes, condro-
blasts or osteoblasts under appropriate culture con-
ditions (Pittenger et al. 1999, Woodbury et al. 2000,
Sekiya et al. 2002), and (2) polygonal shaped cells
similar to epithelial cells positive for prolyl-4-hydro-
xilase (4PH) (Figure 4B), a marker of ﬁbroblasts
unable to maturate. Both spindle and polygonal
stromal cells strongly inhibit (range 50–90%, mean
70%, n ¼ 6) the proliferation of T lymphocytes in
MLR when added at a MSC/Tresponder ratio of 1:2–
1:5 (Figure 4C). Furthermore, the amount of TGFb
spontaneously released in culture by both types of
MSC from the same donor was similar (Figure 4D).
Thus,bothphenotypicandfunctionalfeaturesofMSC
obtained under our culture conditions were in
agreement with what previously reported (Di Nicola
etal.2002,Tseetal.2003,LeBlanc2003,Potianetal.
2003, Djouad et al. 2003, Meisel et al. 2004, Le Blanc
et al. 2004, Beyth et al. 2005, Aggarwal and Pittenger
2005).
Figure 4. Morphological, phenotypic and functional characterization of BMSC. Panel (A). Culture of BMSC was analyzed by inverted
microscope (300 £ magniﬁcation). Upperquadrant;polygonalshapedBMSC on14d. Lowerquadrant: SpindleshapedBMSCon 14d. Panel
(B). Polygonal shaped BMSC (upper histograms) or spindle shaped BMSC (lower histograms) were analyzed for the expression of the
indicated receptors by indirect immunoﬂuorescence. Thin grey histogram; staining of cells with an unrelated isotype matched mAb. Bold
black histogram; staining with mAb to the indicated antigen. Resultsare expressed as meanred ﬂuorescence intensity vs number of cells.Panel
(C). Effect of BMSC on mixed lymphocyte reaction (MLR). 2 £ 10
4 irradiated BMSC of three different donors (BMSC1,B M S C 2,B M S C 3)
were added, as a third party, at the onset of the MLR (MLR1 and MLR2,1 0
5 responder cells vs 10
5 irradiated stimulator cells) and
3H-
thymidine uptake was evaluated on 7d. Results are expressed as cpm £ 10
23. Panel (D). TGFb production evaluated by ELISA of BMSC:
2 £ 10
4 BMSC derived from Pt3, Pt4, Pt5 (Pt5-1: spindle shaped; Pt5-2: polygonal shaped), Pt8, Pt9, Pt10, Pt11 (Pt11-1: spindle shaped;
Pt11-2: polygonal shaped; HD1 (HD1-1 spindle shaped; HD1-2 polygonal shaped) Results are expressed as pg/ml/2 £ 10
4 cells and are the
mean ^ SD of triplicate samples.
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role of LFA1 and NKp30
To determine the outcome of NK–BMSC interaction,
we isolated ex vivo NK cells from peripheral blood or
bone marrow of healthy donors. Thus we investigated
whether NK–BMSC interaction could lead to
activation and/or release of cytokines by NK cells
(Poggi et al. 2005). We found that NK cells released
IFN-g and TNF-a together with IL10 (Figure 5A)
upon binding with BMSC together with the upregula-
tion of the activation antigen CD69 and the de-novo
expression of CD25 (not shown). Accordingly, FACS
and microscopic analysis revealed that NK cells
became blasts when co-cultured with BMSC. The
binding between NK and BMSC was needed to
induce NK cell triggering as when NK were separated
from BMSC by a transwell porous membrane, or by
the addition of a combination of anti-FLA1 and anti-
ICAM1 mAbs, the amount of IFN-g and/or TNF-a
detected in NK–BMSC co-culture supernatant was
negligible or highly reduced, respectively (Figure 5B).
Further, the anti-NKp30 mAb, but not anti-NKp46
mAb, inhibited (range of inhibition 65–85%; n ¼ 4)
cytokine production suggesting that this NK cell
activating receptor may recognize on BMSC its
counterligand (Figure 5B).
Interaction between IL2-activated NK cells and BMSC:
role of LFA1 and NKG2D
BMSC may favour cell proliferation and produce
soluble factors involved in myeloid precursor matu-
ration and differentiation (Rodriguez Mdel et al.
2004, Podesta et al. 2005, Vodyanik et al. 2005).
Thus, we analysed whether IL2-activated NK cells
can affect BMSC survival, like it happens with self
APC. Again, IL2-activated NK cells efﬁciently lysed
self-BMSC and this killing was evident at very low
effector target cell ratios implying that during the
interaction of a single NK cell with one BMSC an
Figure 5. NK cell-mediated cytolytic activity and release of cytokines is triggered by BMSC. Panel (A). Co-culture of ex vivo isolated NK
cells with BMSC induces production of IFN-g, TNF-a and IL10. Panel (B). IFN-g and TNF-a production are dependent on NK–BMSC
contact (no production of these cytokines in the absence of NK–BMSC contact: (NK–BMSC TW) and are down-regulated by the covering
of LFA1 and/or NKp30 with speciﬁc mAb. Results are expressed as ng/ml/10
6 cells. Panels (C) and (D). NK cell-mediated lysis of self-BMSC
is dependent on LFA1-ICAM1 interaction (C) and the triggering of NKG2D through the engagement of MIC-A or ULBP3 is responsible for
the delivering of lethal hit as demonstrated by the use of the speciﬁc mAb. Results are expressed as %
51Cr speciﬁc release in a 4h cytolytic
assay at effector (NK cell) target (self APC) (E:T) ratio of 10:1, 5:1, 2:1 (C) and (D) and 1:1 (C). Panel (E). NK cells revert the inhibitory
effect of BMSC on lymphocyte proliferation in MLR. Results are expressed as
3H-thymidine uptake (cpm) and are the mean ^ SD of
triplicate samples.
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BMSC by NK cells was strongly reduced by the
addition to the cytolytic assay of the calcium chelator
EGTA (not shown), the presence of anti-LFA1 mAb
and/or anti-ICAM1 mAb (Figure 5C), or the vacuolar
H þ -ATPase inhibitor concanamycin A (Poggi et al.
2005) indicating that both calcium increase and
release of perforins, conceivably consequent to NK–
BMSC binding, are involved (Woo et al. 1998). The
addition to the cytolytic assay of any combination of
anti-NCR mAb, by contrast of what observed using
APC as target cells (see above), did not result in a
strong inhibition of BMSC lysis (not shown).
Recently, it has been reported that also NKG2D
activating receptor (Bauer et al. 1999, Diefenbach
et al. 2000, Cosman et al. 2001, Pende et al. 2002,
Groh et al. 2002, Poggi et al. 2004) can deliver a
triggering signal in cytolytic CD8
þT lymphocytes and
NK cells, leading to the lysis of tumor target cells that
upregulate at the cell surface the NKG2D counter-
ligands represented by the MHC-I-related stress
inducible molecule A (MIC-A) or (MIC-B) or the
UL-16 binding proteins (ULBP1–4). The addition of
anti-NKG2D mAb to the cytolytic assay inhibited by
40–80% (n ¼ 4) the lysis of BMSC exerted by IL2-
activated NK cells and this inhibitory effect was
comparable to that obtained with anti-ULBP3 and/or
anti-MIC-A mAb were used in combination (Poggi
et al. 2005). Indeed, the expression of NKG2D
ligands ULBP3, together ULPB1 and 2, and MIC-A
on BMSC were conﬁrmed by ﬂow cytometry and
microscopic analysis (not shown). The addition of
PI-3K inhibitors (LY294002 or wortmannin) reduced
the NK cell-mediated lytic effect on BMSC, further
conﬁrming the involvement of NKG2D in delivering
the lethal hit (Bauer et al. 1999, Poggi et al. 2004).
Finally, the addition of anti-HLA class I mAb to the
cytolytic assay did not enhance the lytic effect exerted
by NK cells on BMSC suggesting that, likewise to
what found using APC as target cells, HLA class I
do not protect BMSC from aggression of self-NK
cells (not shown) (Bauer et al. 1999, Poggi et al.
2004).
The veto cell effect on mixed lymphocyte reaction mediated
by BMSC is down-regulated by NK cells
Both the spindle type (bona ﬁde MSC) or the
polygonal type of stromal cells derived from bone
marrow can inhibited MLR when added as a third
party (Figure 4C). To determine whether the
elimination of these BMSC types by NK cells would
result in the downregulation of the BMSC-mediated
tolerogenic effect and thus in restoring immune cell
response to allogeneic stimulator, we performed MLR
in the presence of BMSC either with or without the
addition of IL2-activated NK cells. We found that the
addition of BMSC to MLR at a responder: BMSC
ratio ranging from 1:1 to 10:1 resulted in a strong
inhibition of lymphocyte proliferation (75–95% of
inhibition; n ¼ 3) (Figure 5E). Importantly, this
inhibitory effect was almost abolished (90–95% of
reconstitution of MLR proliferation) when NK cells
were added to MLR/BMSC co-cultures (Figure 5E).
NK cells exert a slightly inhibitory effect on MLR
(10–15% of inhibition), probably due to consuming
of IL2 produced during the interaction between
responder and stimulating cells; thus, it is conceivable
that the reconstitution of MLR proliferation is
essentially due to the elimination of veto effect exerted
by BMSC. Polygonal BMSC as well spindle BMSC
(containing MSC) were able to inhibit MLR
indicating that the veto activity was not conﬁned to
MSC; this would suggest that different BMSC can be
used in vivo to different purposes: BMSC containing
MSC to repair tissues and BMSC without differ-
entiating potential to counteract GVHD or in
autoimmune diseases. However, both these BMSC
types were sensitive to NK cell-mediated lysis
implying that NK cells might affect their in vivo
survival, possibly impairing the BMSC-dependent
therapeutic effect.
Interaction between NK cells and stromal cells derived
from skin
The ﬁnding that NK cells can be activated by
interaction with self-BMSC prompted us to analyse
whether the binding between NK and stromal cells
isolated from other tissues can have a similar outcome.
Phenotypic analysis of stromal cell populations
derived from skin biopsies, thymus and lymph nodes
revealed that they do not differ from BMSC for the
expression of several surface markers. Indeed, MIC-A
and ULBP1, 2 and 3, beside ICAM1 and HLA class I,
were present on any kind of stromal cell (not shown).
Microscopic analysis showed that these cell popu-
lations display, although intracytoplasmic positive for
the enzyme 4PH involved in the hydroxylation of
collagen, a ﬁbroblast-like morphology similar to that
of spindle like BMSC. To determine whether stromal
cells isolated from tissues other than bone marrow can
exert a veto effect on MLR or on activation of T
lymphocytes, we performed MLR or lymphocyte
stimulation with PHA or anti-CD3 mAb, in the
presence of skin stromal cells (Figure 6A). Unexpecte-
dly, proliferation in MLR was strongly inhibited by the
presence of stromal cells (Figure 6A) likewise the
lymphocyte activation and proliferation through the
CD3/TCR engagement or upon stimulation with
PHA (Figure 6B). IL2-activated NK cells killed self-
stromal cells upon ligation of NKG2D and LFA1 as
reported above for BMSC (Figure 6C). Indeed, the
addition of anti-NKG2D or anti-LFA1 mAbs to the
cytolytic assay led to a consistent inhibition of NK
cell-mediated stromal cell lysis. On the other hand,
A. Poggi & M. R. Zocchi 332anti-NKp30 and/or anti-NKp46 mAbs have a
marginal effect on this lysis. Similar to what observed
with BMSC, the HLA class I appears to marginally
protect stromal cells obtained from skin (not shown).
More importantly, NK cells reverted the inhibitory
effect on MLR induced by stromal cells (Figure 6D)
indicating that NK cells upset the veto effect of
stromal cells.
Concluding remarks
NK cell activation against self should be inhibited by
the engagement of inhibitory members of the IRS.
The present ﬁndings, together with other reports
(Carbone et al. 1999, Wilson et al. 1999, Parajuli et al.
1999, Spaggiari et al. 2001, Ferlazzo et al. 2002,
Pende et al. 2005, Poggi et al. 2005), point out the
possibility that NK cells can efﬁciently interact with
self-cells leading to cytokine production and activation
of lytic machinery. This, in turn, induces killing and
damage of self-APC and/or stromal cells (Figure 7).
These ﬁndings give rise to two obvious questions:
“When does this happen?” and “Which are the
regulating mechanism(s) involved?” We can simply
hypothesize that NK cells and APC or stromal cells do
not encounter themselves in healthy subjects, thus
self-aggression will not take place. Against this, it is the
ﬁnding that NK cells have been found in primary and
secondary lymphoid organs (Poggi et al. 1990,
Mingari et al. 1991, Ferlazzo et al. 2004) where the
interaction between APC and immature/immuno-
incompetent (within the thymus) or mature/immuno-
competent (in lymph nodes) T cells is essential to
avoid self-recognition and mount an efﬁcient immune
response. It is conceivable that virus-induced NK cell
activation at the site of infection can result in
Figure 6. Effect of skin-derived stromal cells on T lymphocyte proliferation: NK cells kill stromal cells and revert their tolerogenic effect.
Panel (A).Self-ﬁbroblasts, autologous to respondercells, inhibit T cell proliferation in MLR.Proliferation was analyzedat 7dof culture. Panel
(B). A similar inhibitory effect is observed on PHA and CD3-driven T cell proliferation (analyzed on d3). Panel (C). NK cells kill skin stromal
cellsdue to theengagementofNKG2D as the maskingofthisreceptorwithspeciﬁcmAbleadsto inhibition oflysis.Panel(D). Theadditionof
NK cells to MLR-skin stromal cells co-culture revert the inhibitory effect mediated by stromal cells. Results are expressed as
3H-thymidine
uptake (cpm) (A, B, D) or as %
51Cr speciﬁc release in a 4h cytolytic assay at effector (E, NK cell) target (T, self APC) ratio of 20:1, 10:1, 5:1
(C).
NCR and NKG2D: Role in self-reaction 333the elimination of APC or stromal cells infected by
viruses limiting virus life cycle and reducing the
spreading of infection. If this is the case, the regulating
mechanism(s), which limit the killing activity and
pro-inﬂammatory cytokine production by NK cells,
once triggered by virus-infected cells, should be timely
switched on. We have shown that the anti-inﬂamma-
tory cytokine TGFb is constitutively produced by
stromal cells while high amounts of IL10 are
detectable in supernatants from NK-stromal cell
co-cultures. These cytokines, together with the
generation of regulatory T cells may have a role in
limiting NK cell-mediated self-reactions.However,we
should keep in mind that cytokines are pleiotropic as
they inﬂuence many elements of immune responses.
Indeed, IL10 can also stimulate B cell proliferation
despite being one of the most potent inhibitors of cell-
mediated immune responses. Similarly, IL2, IL6,
TNF-a and IFNs have a well-characterized pro-
inﬂammatory effect, but they can have suppressive
activities as well. The discovery of IL23 which
stimulates IL17 production, playing a role in auto-
immunity or protective response to infections,
together with the observation that IL27 can have
both pro- and anti-inﬂammatory effects, further
support the notion that the cytokine network have a
major role in inﬂuencing the outcome of immune
response (Hunter 2005). In this context, NK cells
bear the correct array of activating surface receptors
able to trigger and consequently regulate adaptive
immune response against self. Thus, the further study
of the functional capabilities of this subpopulation of
the innatearm of immune responsecan lead to a better
understanding of the generation of self-aggression and
autoimmune disease.
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